Hepatitis C viral infection after liver transplantation
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
Ranjeeta Bahirwani, K. Rajender Reddy – 23 July 2012 – Watch the interview with the authors
Douglas Mogul, Kathleen B. Schwarz – 23 July 2012 – Watch an interview with Dr. Schwarz
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
Andres F. Carrion, Paul Martin – 23 July 2012 – Watch the interview with the authors
Rania Rabie, Khalid Mumtaz, Eberhard L. Renner – 23 July 2012 – Cyclosporine A (CSA), but not tacrolimus (TAC), inhibits hepatitis C virus (HCV) replication in vitro. Clinical reports on the efficacy of interferon‐α (IFNα)–based antiviral therapy (AVT) for recurrent HCV after liver transplantation (LT) with CSA and TAC are conflicting. Our aim was to assess whether AVT for recurrent HCV after LT is more effective with CSA or TAC. We performed an electronic database search (1995‐2012) and a manual abstract search (2005‐2012).
Jason Schwartz, Heather Thiesset, Terry Box, William Hutson, John Sorensen – 23 July 2012
Qinggong Yuan, Komal Loya, Bhavna Rani, Selina Möbus, Asha Balakrishnan, Jutta Lamle, Toni Cathomen, Arndt Vogel, Michael P. Manns, Michael Ott, Tobias Cantz, Amar Deep Sharma – 23 July 2012 – The tightly controlled replication of hepatocytes in liver regeneration and uncontrolled proliferation of tumor cells in hepatocellular carcinoma (HCC) are often modulated by common regulatory pathways. Several microRNAs (miRNAs) are involved in HCC progression by modulating posttranscriptional expression of multiple target genes.
Diana L. Sylvestre – 23 July 2012 – Watch an interview with the author
Nezam H. Afdhal – 23 July 2012 – Watch a video presentation of this article